- Investing Ideas
- /
- Global Undervalued Stocks Based On Cash Flows
Global Undervalued Stocks Based On Cash Flows
Results
984
0 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
984 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
9658 | HK$12.92 | -9.3% | -6.1% | HK$8.7b | HK$16.74 | PE69.1x | E48.4% | n/a | Consumer Services | ||
TRUE B | SEK 35.66 | 1.5% | -20.5% | SEK 12.3b | SEK 54.83 | PE25.8x | E21.4% | 1.1% | Software | ||
UMBF | US$94.71 | 2.5% | 36.5% | US$4.6b | US$97.17 | PB1.5x | E21.8% | 1.6% | Banks | ||
ALNSE | €25.50 | 11.8% | 17.0% | €81.0m | €27.80 | PE19.6x | E20.2% | 0.9% | Capital Goods | ||
SACH | US$2.61 | -8.4% | -28.1% | US$123.8m | US$4.33 | PE10.7x | E17.4% | 16.9% | Diversified Financials | ||
FEX | AU$0.39 | 1.3% | 20.3% | AU$270.9m | n/a | PE6.6x | E24.6% | 5.2% | Materials | ||
2899 | HK$16.20 | -8.4% | 29.8% | HK$493.8b | HK$20.85 | PE18.3x | E21.3% | 1.7% | Materials | ||
MXI | AU$2.00 | 7.5% | -24.5% | AU$114.7m | AU$2.74 | PE17.2x | E28.9% | 2.9% | Capital Goods | ||
TFBANK | SEK 260.00 | 3.6% | 59.9% | SEK 5.6b | SEK 270.67 | PB2.3x | E27.7% | n/a | Banks | ||
FLNC | US$15.96 | -4.2% | -44.0% | US$2.9b | US$28.08 | PB4.9x | E101.3% | n/a | Capital Goods | ||
STX | AU$0.20 | -4.7% | -52.9% | AU$572.2m | n/a | PE294.7x | E36.1% | n/a | Energy | ||
NEXN | UK£2.38 | 0.8% | -18.5% | UK£328.2m | UK£10.00 | PS1.3x | E117.9% | 0% | Media | ||
RAY B | SEK 139.80 | 0.4% | 99.1% | SEK 4.8b | SEK 195.00 | PE47.6x | E33.6% | 0.5% | Healthcare | ||
MUSTI | €26.80 | 0.4% | 54.6% | €894.8m | €28.00 | PE57.3x | E37.0% | 2.2% | Retail | ||
600882 | CN¥13.56 | 1.8% | -34.5% | CN¥6.9b | CN¥16.59 | PE84.5x | E36.6% | 0% | Food, Beverage & Tobacco | ||
688513 | CN¥33.48 | 9.6% | -1.0% | CN¥5.7b | CN¥51.02 | PE24.3x | E22.0% | 1.2% | Pharmaceuticals & Biotech | ||
HNL | €17.40 | 5.5% | -22.7% | €105.5m | €25.20 | PS1x | E121.4% | n/a | Capital Goods | ||
SMAR | US$48.29 | 8.6% | 15.9% | US$6.7b | US$53.26 | PS6.7x | E56.0% | n/a | Software | ||
688046 | CN¥10.98 | 13.0% | -41.6% | CN¥4.2b | CN¥18.71 | PE28.6x | E23.6% | 1.5% | Pharmaceuticals & Biotech | ||
CY1K | €2.90 | -1.4% | -57.0% | €28.1m | €7.00 | PB0.8x | E102.7% | n/a | Capital Goods | ||
6871 | JP¥5,930.00 | -18.1% | 178.3% | JP¥246.9b | JP¥9,166.67 | PE53.3x | E39.8% | 0.6% | Semiconductors | ||
7030 | ر.س11.20 | 2.0% | -18.8% | ر.س10.1b | ر.س13.15 | PE51.3x | E43.0% | 4.5% | Telecom | ||
2233 | HK$1.09 | 0% | 43.4% | HK$6.1b | HK$1.49 | PE13.1x | E46.9% | 2.3% | Materials | ||
2083 | ر.س63.00 | 4.3% | -23.2% | ر.س16.0b | ر.س80.75 | PE34.1x | E28.4% | 3.5% | Utilities |